Targeting autophagy for AILI treatment Autophagy is a tightly regulated cellular process that renew cell through removing unwanted cytoplasmic contents, including misfolded or aggregated proteins, accumulated lipids, excessive or damaged organelles and harmful pathogens, via lysosomal degradation [80]
Similarly, H7, A8 and F12 of GLP-1 interact with E 364 and F 367 of TM6 of GLP-1R, whereas, Igl2 of SR18 forms hydrophobic interactions with F 367
Cardiovascular outcome trials for liraglutide, semaglutide, and dulaglutide demonstrated modest blood pressure reductions alongside reduced major adverse cardiovascular events
Each one works a little differently, so the right choice should depend on your labs, goals, tolerance, and medical history